Legacy DNA’s Market Strategy Advice

Legacy DNA’s Market Strategy Advice

MPO's Sean Fenske speaks with Dr. Roxie Mooney of Legacy DNA about how she helps clear a medical device manufacturer’s pathway to market.

By Sean Fenske, Editor-in-Chief05.25.21
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Roxie Mooney, the CEO and Healthcare Commercialization Strategist of Legacy DNA. She shares a number of best practices for companies determining their pathway to market for a new medical device. She also shares ideas and strategies for how medical device manufacturers can better leverage marketing channels to target a specific audience. Specifically, the following questions are addressed.

  • What is Legacy DNA and how are you helping medical device manufacturers?
  • What’s the biggest or most common mistake you see with regard to a company’s market strategy?
  • What are some of your best suggestions for getting to market and gaining market share?
  • How did the pandemic disrupt device manufacturers’ pathway to market?
  • Do you anticipate any lasting changes with regard to a firm getting to market or do you expect an eventual return to business as usual?

Listen to this episode and see what you think of the suggestions provided and how they could affect your market startegy. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.